Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32

Recent Results Cancer Res. 1981:76:7-15. doi: 10.1007/978-3-642-81565-2_2.
No abstract available

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Drug Evaluation, Preclinical
  • Humans
  • Middle Aged
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Rabbits

Substances

  • Antineoplastic Agents
  • valrubicin
  • Doxorubicin